Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort
Sign Up to like & getrecommendations! Published in 2023 at "United European Gastroenterology Journal"
DOI: 10.1002/ueg2.12365
Abstract: Abstract Background We aimed to investigate the efficacy of postoperative adjuvant transarterial chemoembolisation (PA‐TACE) in patients with hepatocellular carcinoma (HCC) complicated by microvascular invasion (MVI). Methods A retrospective analysis of 1505 patients with HCC who… read more here.
Keywords: adjuvant transarterial; postoperative adjuvant; hepatocellular carcinoma; tace ... See more keywords
CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation
Sign Up to like & getrecommendations! Published in 2021 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-021-02968-1
Abstract: This CIRSE Standards of Practice document is aimed at interventional radiologists and provides best practices for performing transarterial chemoembolisation. It has been developed by an expert writing group under the guidance of the CIRSE Standards… read more here.
Keywords: standards practice; practice; cirse standards; transarterial chemoembolisation ... See more keywords
Metachronous double‐hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia‐like atypia in the gallbladder and stomach—A diagnostic pitfall
Sign Up to like & getrecommendations! Published in 2022 at "Histopathology"
DOI: 10.1111/his.14653
Abstract: A 41-year-old female was diagnosed with ocular malignant melanoma in May 2020. In August 2021, she presented with hepatic metastases affecting both lobes with lesions measuring up to 12 mm in diameter. Transarterial chemoembolisation (TACE)… read more here.
Keywords: transarterial chemoembolisation; tace; chemoembolisation tace; tace fotemustine ... See more keywords
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-065839
Abstract: Introduction Hepatocellular carcinoma (HCC) is a common cause of cancer-related death, often detected in the intermediate stage. The standard of care for intermediate-stage HCC is transarterial chemoembolisation (TACE), where idarubicin (IDA) is a promising drug.… read more here.
Keywords: hepatocellular carcinoma; transarterial chemoembolisation; treatment; response ... See more keywords